A randomized clinical comparative study of Karanjadi oil (a hypothetical compound oil) and Rasanjanadi lepa in the management of Dadru In Children
Trial Snapshot
- Phase
- Phase 2/3
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Change in subjective and objective criteria Dadru
Study Overview
Brief Summary
Skin ailments are common in children. Children are particularly susceptible to dermatophytic infections because of their poor personal hygiene habits and poor environmental sanitation. Superficial tinea infections are some of the most common dermatological conditions in children. Hence, it gives negative impact on health and well-being of children. The Tinea infections are prevalent globally but they are common in tropics and may reach epidemic proportions in geographical areas with higher humidity, over-population and poor hygienic living conditions. They can spread by direct contact from other people (anthropophilic organisms), animals (zoophilic organisms), and soil (geophilic organisms), as well as indirectly from fomites. According to Acharya Charaka, Nidana sevan leads to prakopa of Tridoshas and thus the vitiated Doshas will get aashrya in Twaka, Rakta, Mamsa and Ambu causing the shaithilyata in these Dhatus leading to the manifestation of Kustha roga. So, the study has been undertaken to understand each and every aspect related to Dadru Kustha and proper management protocol. Ayurvedic management is very helpful to improve the life of children suffering from Dadru Kustha.
Study Design
- Study Type
- Interventional
- Allocation
- Computer generated randomization
- Masking
- Not Applicable
Eligibility Criteria
- Ages
- 3.00 Year(s) to 16.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •1.Parents of children willing to participate in the research trial.
- •2.The patients with lakshans (Sign & Symptoms) of Dadru.
- •3.Children of either sex aged between 3 years to 1.
Exclusion Criteria
- •Children below 3 years and above 16 years of age.
- •Children under long standing medication.
- •Chronicity more than 2 years.
- •Patient suffering with systemic disorders like auto immune disease etc., which interfere with the course of treatment, will be excluded.
- •Dadru associated with other skin disease will be excluded.
Outcomes
Primary Outcomes
Change in subjective and objective criteria Dadru
Time Frame: 4 weeks
Secondary Outcomes
- 1.To collect literature of Dadru from different medical texts of Ayurveda and modern.(2.To understand and analyze the disease Dadru in relation with Tinea.)